NCT02980926View on ClinicalTrials.gov

Mepivacaine vs. Bupivacaine Spinal Anesthetic in Total Knee Arthroplasty

PHASE4CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

March 31, 2017

Study Completion Date

March 31, 2017

Conditions
Anesthesia, SpinalArthroplasty, Replacement, KneePain ManagementEarly AmbulationAmbulatory Surgical Procedures
Interventions
DRUG

Mepivacaine

This is a shorter acting spinal anesthetic as compared to the current standard of care at this institution.

DRUG

Bupivacaine

This is the current standard of care at this institution and many centers. This is a longer acting spinal anesthetic compared to the study drug.

Trial Locations (1)

48322

Henry Ford West Bloomfield, West Bloomfield

All Listed Sponsors
lead

Henry Ford Health System

OTHER

NCT02980926 - Mepivacaine vs. Bupivacaine Spinal Anesthetic in Total Knee Arthroplasty | Biotech Hunter | Biotech Hunter